lets get the facts right folks ... when chevron took over Texaco petroleum , part of texaco (texpet) was a minority partner in an exploration and production venture with petroecuador, ecuador's stateowned oil company , at the time of take over petroecuador assumed all responsibility for the clean up in ecuador. FACT
VANCOUVER , Nov. 20, 2013 /CNW/ - Taseko Mines Limited (TSX: TKO NYSE MKT: TGB) ("Taseko" or the "Company") announces that it has entered into an agreement to acquire 11,666,667 common shares of Curis Resources Ltd. ("Curis") at a price of $0.60 per share pursuant to a private placement for subscription proceeds of $7 million .
Upon receipt of TSX approval, Taseko will complete the acquisition of 3,333,333 of these shares, and will complete the acquisition of the remaining 8,333,334 shares at or about January 2, 2014. Taseko currently holds approximately 2% of Curis' issued shares, prior to the closing of this private placement. After completion of this private placement, Taseko will hold a total of 12,916,667 shares of Curis, representing approximately 17% of the shares of Curis currently issued and outstanding.
Curis Resources is a publicly traded company with a 100% interest in the Florence Copper Project in Arizona . All of these shares of Curis are held directly by Taseko and are being held for investment purposes. Taseko may in the future take such actions in respect of its Curis shares as it deems appropriate in light of the market circumstances then existing, including the potential purchase of additional shares of Curis through open market purchases or privately negotiated transactions, or the sale of all or a portion of such holdings in the open market or in privately negotiated transactions to one or more purchasers. There are no persons acting jointly or in concert with Taseko with respect to Taseko's shareholdings in Curis, nor has Taseko entered into any agreements in respect of its shareholdings in Curis with any person with which Taseko acts jointly or in concert
from the motley fool nov 6 2013 cris was down today due to the announcement that early-stage cancer drug CUDC-427 had been placed on partial clinical hold by the Food and Drug Administration, which will negate any chance of Curis enrolling any new patients into its phase 1 study. The reason behind the hold is due to the death of a patient from liver failure that occurred one month after this patient stopped taking CUDC-427. In the interim, Curis will need to provide the FDA with additional safety and efficacy information in the hope that it will lift the partial clinical hold.
though it's a disappointing setback. This by no means is a deathblow to CUDC-427 as the two events (taking CUDC-427 and the subsequent liver failure) may be completely unrelated, but it does halt research (for now) into a potentially exciting new anti-cancer therapy for advanced or refractory solid-tumors or lymphomas.
one person died that was in a clinical trail for a new drug . they don't know if the death had anything to do with trial or the sick person was just to ill to start with.(you must some illness to be invited to take part in a new drug trial) the trial was halted to find out. read people! do not trust anyone on a message board. 99.9 percent of them ARE going to try to trick you out of you money